Genelux (GNLX) closed at $2.17 on November 20, 2026, down 4.8% from the previous close, on volume of 310,856 shares (30-day average 382,751).
Data as of November 20, 2026.
20-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 20, 2026. See the largest for 5, 30, 60 and 90 days
TipRanks (Fri, 20-Nov 1:45 AM ET)
Genelux Corporation Reports Third Quarter Financial Results and Provides Business Updates
Globe Newswire (Mon, 16-Nov 4:14 PM ET)
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
Genelux trades on the NASDAQ stock market under the symbol GNLX.
As of November 20, 2026, GNLX stock price declined to $2.17 with 310,856 million shares trading.
GNLX has a beta of -0.12, meaning it tends to be less sensitive to market movements. GNLX has a correlation of 0.00 to the broad based SPY ETF.
GNLX has a market cap of $103.36 million. This is considered a Micro Cap stock.
In the last 3 years, GNLX traded as high as $16.60 and as low as $1.60.
The top ETF exchange traded funds that GNLX belongs to (by Net Assets): VTI, VXF, IWC.
GNLX has underperformed the market in the last year with a return of -53.2%, while the SPY ETF gained +6.9%. In the last 3 month period, GNLX fell short of the market, returning -20.8%, while SPY returned -9.3%. However, in the most recent 2 weeks GNLX has outperformed the stock market by returning +10.7%, while SPY returned -6.2%.
GNLX support price is $2.13 and resistance is $2.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GNLX shares will trade within this expected range on the day.